FindDrugs.org

Sprout Health Review

Brand-level review · Last reviewed Sep 14, 2026

5.32/10

Operator-trust score

The brand-level factors every category shares — legitimacy, clinical oversight, transparency, privacy, policy, support — not price or per-treatment value.

No commitmentFastest startCash-pay

Our verdict

Sprout Health is a cash-pay telehealth brand operated by Sprout Health Partners LLC of Encinitas, California, selling compounded semaglutide and tirzepatide through an asynchronous intake that requires no labs in most states. Its operator-trust score is 5.32 — the brand-level factors every category shares, not price or per-treatment value. It publishes starting prices on its own site and charges no membership or consultation fee. The record against it is the substance of its score: a September 2025 FDA misbranding warning letter over FDA-approval claims, a BBB F rating driven by unanswered complaints, the thinnest review base in this set, and a compounding pharmacy it names nowhere.

Sprout Health plans & reviews by category

Each category is scored separately. Read the full review where one exists — or check current pricing directly.

Weight Loss / GLP-1

5.26/10
Read the Weight Loss / GLP-1 reviewCheck price
  • Semaglutide · injection$249/mo
  • Tirzepatide · injection$299/mo

Prices as of Sep 14, 2026 — verify current on the brand's site.

Key takeaways

  • Publishes starting prices on its own site — compounded semaglutide from $149/month and tirzepatide from $199/month — with no membership or consultation fee. "Starting at" is not a dose-locked rate, and no dose-lock commitment appears on its pages.
  • Names no compounding or dispensing pharmacy on its own site; the pharmacy names previously reported came from a syndicated press release rather than from the brand or an independent record.
  • A September 2025 FDA warning letter cited false or misleading 'FDA-approved' claims.
  • Its accreditation badge is a claim by the brand rather than a verified registration: the public checker returned no retrievable certification record for the domain.
  • Prescriptions issue fast — same or next business day, with no labs required — but fulfilment shipping is frequently delayed beyond the advertised window.
  • A written refund and cancellation policy exists, but pervasive complaints about inability to cancel and forced chargebacks indicate poor real-world fairness.
  • Unresponsive customer service is the single most consistent complaint against it.
  • Its 115 Trustpilot reviews at 3.6/5 are the thinnest review base in this set, and the only independently checkable indicator of its reach.

What is Sprout Health?

Sprout Health is a direct-to-consumer weight-loss telehealth platform operated by Sprout Health Partners LLC, based in Encinitas, California and founded in 2023. It connects patients with licensed providers through the MD Integrations network and prescribes compounded semaglutide and tirzepatide, dispensed through pharmacies it names nowhere on its own site. It is available in roughly 44 states, excluding Alabama, Arkansas, Mississippi, Louisiana, California and North Dakota, and in most states requires neither lab work nor a live telehealth visit — screening is handled through an online questionnaire. Sprout Health Partners LLC is the entity named in the FDA’s September 9, 2025 warning letter; it should not be confused with unrelated companies sharing the Sprout Health name.

Is Sprout Health legit?

Qualified. Sprout Health Partners LLC is a real operating entity, but the things that would establish more than that do not check out: it advertises an accreditation that could not be confirmed on the registry’s public directory and rests on the company’s own statements, it received an FDA misbranding warning letter in September 2025, and it carries a BBB F rating for unanswered complaints. Its clinical oversight is asynchronous, with no labs and no required live visit in most states.

  • Licensed & accredited: A real operating entity (Sprout Health Partners LLC, Encinitas CA) with a company-asserted accreditation that could not be independently verified on accreditation-registry's public directory, offset by an FDA misbranding letter and a BBB F rating — FDA warning letter (ref. 715879) / BBB profile, 2025-2026.
  • Clinician model: Licensed providers via MD Integrations, but intake is asynchronous with no labs and no required live visit in most states — ManyTreatments, Jul 2026.
  • Medication & pharmacy: Dispenses compounded semaglutide and tirzepatide through pharmacies it does not name publicly; 503A/503B classification is reported differently across sources — ManyTreatments, Jul 2026.
  • Watch-outs: A September 2025 FDA warning letter cited false/misleading 'FDA-approved' claims, and BBB complaints cite cancellation difficulty and shipping delays — FDA warning letter / BBB profile, 2025-2026.

Treatment options

What Sprout Health actually treats. Pricing lives in the plans table above and in each category review.

  • Weight loss (GLP-1)

    compounded semaglutide and tirzepatide by injection

Pros & cons

Pros

  • LegitScript certification advertised by the company (not independently verifiable on LegitScript’s directory)
  • No contracts, no membership or consultation fees; month-to-month
  • Fast prescription turnaround (same/next business day, no labs required)
  • Disclosed provider network (MD Integrations)

Cons

  • FDA warning letter (Sept 9, 2025) for false/misleading FDA-approval claims
  • BBB F rating; failure to respond to complaints
  • Widespread cancellation difficulty - customers report resorting to chargebacks
  • Shipping delays (advertised 5-7 days often 2-5 weeks per complaints)
  • Async quiz-only screening with no required labs; homepage lacks named clinicians/eligibility

The bottom line

Sprout Health suits price-focused shoppers who are comfortable with a light-touch, message-based care model and who will manage the subscription closely. Anyone who wants responsive support, hands-on clinical oversight, disclosed sourcing or a clean regulatory record should compare higher-ranked alternatives first.

What changed & why

This brand's own history — every re-review and methodology recompute, logged. Rankings change when the evidence or the rules change, never for payment. See the site-wide methodology ledger for version history.

  1. Sep 18, 2026Initial score5.32

    Sprout Health's Operator Trust Score first recorded at 5.32 out of 10 — the earliest score in this log.

Review score changes

The timeline above is this brand's Operator Trust Score. Each review below is scored separately, and keeps its own history.

  • Weight Management / GLP-1 review— last changed Sep 14, 2026See changes

Work at Sprout Health?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Completeness was not recorded for this score · 5 sources cited

Regulatory

Reviews

Other

What we couldn't verify

  • Two unrelated 'Sprout Health' entities exist; this review confirms the DTC compounded-GLP-1 brand is Sprout Health Partners LLC at joinsprouthealth.com (Encinitas, CA), named in the FDA's Sept 9, 2025 warning letter.
  • Pharmacy 503A vs 503B status reported differently across sources and not confirmed on Sprout's own site.
  • Advertised compounded pricing varies materially by source ($149 vs $249 semaglutide).
  • FDA warning letter page returned 404 on direct fetch; corroborated via FDA search listing and Pharma Now.
  • Trustpilot now verified 3.6/115 (rendered fetch 2026-07-24); low volume (115 reviews) keeps it a weak signal.
  • Withdrawn — Sprout Health's named partner pharmacies (Foothills Pharmacy, Promise Pharmacy). Sprout Health's named partner pharmacies (Foothills Pharmacy, Promise Pharmacy) are WITHDRAWN. The source is described in our own payload as "syndicated GlobeNewswire/Yahoo Finance PR coverage" — a wire release, which the 2026-08-06 ruling rejects — and joinsprouthealth.com names no pharmacy (fetched 2026-08-10).
  • Withdrawn — Sprout Health's "dose-locked pricing" claim. Sprout Health's "dose-locked pricing" claim is WITHDRAWN — same syndicated release; joinsprouthealth.com states starting prices ("Starting at $149 month" semaglutide, "Starting at $199 month" tirzepatide) with no dose-lock guarantee (fetched 2026-08-10).
  • Withdrawn — third-party assertion that Sprout Health is "HIPAA compliant; LegitScript certified". The third-party assertion that Sprout Health is "HIPAA compliant; LegitScript certified" is WITHDRAWN. It directly CONTRADICTS this payload's own legitimacy finding, which records that LegitScript's checker returned no retrievable certification record for joinsprouthealth.com. Two citations in one payload cannot say opposite things; the one that says "unverifiable" is the one that did the checking.
  • Withdrawn — Sprout Health's momentum signal. Sprout Health's momentum signal is WITHDRAWN as evidence. The citation's own quote described it: "Syndicated GlobeNewswire/Yahoo Finance PR coverage of Sprout Health GLP-1 program in 2026." A brand's own press release circulating is not evidence that the brand is growing.
  • data-privacy-security: re-encoded as a RETRIEVAL GAP (excluded, re-normalized out of the score) rather than brand opacity. Sprout's own footer carries a HIPAA notice link and a LegitScript badge — it DOES disclose in kind. What failed is verification: LegitScript's checker is reCAPTCHA-gated and returned no retrievable record. Retrieval failure, not opacity.
  • glp1-titration-autonomy: re-encoded as a RETRIEVAL GAP (excluded, re-normalized out of the score) rather than brand opacity. The withdrawn "dose-locked pricing" claim came from a wire release. Sprout publishes "Starting at" prices, which contradicts it — but we did not establish that Sprout fails to publish a titration policy, only that a favourable claim about one was badly sourced.
Last reviewed Sep 14, 2026View the ledger